Suppr超能文献

从噬菌体制剂中去除内毒素和肠毒素

The Removal of Endo- and Enterotoxins From Bacteriophage Preparations.

作者信息

Hietala Ville, Horsma-Heikkinen Jenni, Carron Annelie, Skurnik Mikael, Kiljunen Saija

机构信息

Department of Bacteriology and Immunology, Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Division of Clinical Microbiology, HUSLAB, Helsinki University Hospital, Helsinki, Finland.

出版信息

Front Microbiol. 2019 Jul 23;10:1674. doi: 10.3389/fmicb.2019.01674. eCollection 2019.

Abstract

The production of phages for therapeutic purposes demands fast, efficient and scalable purification procedures. Phage lysates have a wide range of impurities, of which endotoxins of gram-negative bacteria and protein toxins produced by many pathogenic bacterial species are harmful to humans. The highest allowed endotoxin concentration for parenterally applied medicines is 5 EU/kg/h. The aim of this study was to evaluate the feasibility of different purification methods in endotoxin and protein toxin removal in the production of phage preparations for clinical use. In the purification assays, we utilized three phages: phage vB_EcoM_fHoEco02, phage vB_ApiM_fHyAci03, and phage vB_SauM_fRuSau02. The purification methods tested in the study were precipitation with polyethylene glycol, ultracentrifugation, ultrafiltration, anion exchange chromatography, octanol extraction, two different endotoxin removal columns, and different combinations thereof. The efficiency of the applied purification protocols was evaluated by measuring phage titer and either endotoxins or staphylococcal enterotoxins A and C (SEA and SEC, respectively) from samples taken from different purification steps. The most efficient procedure in endotoxin removal was the combination of ultrafiltration and EndoTrap HD affinity column, which was able to reduce the endotoxin-to-phage ratio of vB_EcoM_fHoEco02 lysate from 3.5 × 10 Endotoxin Units (EU)/10 plaque forming units (PFU) to 0.09 EU/10 PFU. The combination of ultrafiltration and anion exchange chromatography resulted in ratio 96 EU/10 PFU, and the addition of octanol extraction step into this procedure still reduced this ratio threefold. The other methods tested either resulted to less efficient endotoxin removal or required the use of harmful chemicals that should be avoided when producing phage preparations for medical use. Ultrafiltration with 100,000 MWCO efficiently removed enterotoxins from vB_SauM_fRuSau02 lysate (from 1.3 to 0.06 ng SEA/10 PFU), and anion exchange chromatography reduced the enterotoxin concentration below 0.25 ng/ml, the detection limit of the assay.

摘要

用于治疗目的的噬菌体生产需要快速、高效且可扩展的纯化程序。噬菌体裂解物含有多种杂质,其中革兰氏阴性菌的内毒素以及许多致病细菌产生的蛋白质毒素对人体有害。肠胃外给药的药物允许的最高内毒素浓度为5 EU/kg/h。本研究的目的是评估不同纯化方法在去除临床用噬菌体制剂生产过程中的内毒素和蛋白质毒素方面的可行性。在纯化试验中,我们使用了三种噬菌体:噬菌体vB_EcoM_fHoEco02、噬菌体vB_ApiM_fHyAci03和噬菌体vB_SauM_fRuSau02。本研究中测试的纯化方法包括用聚乙二醇沉淀、超速离心、超滤、阴离子交换色谱、辛醇萃取、两种不同的内毒素去除柱及其不同组合。通过测量噬菌体滴度以及来自不同纯化步骤的样品中的内毒素或葡萄球菌肠毒素A和C(分别为SEA和SEC)来评估所应用纯化方案的效率。去除内毒素最有效的程序是超滤和EndoTrap HD亲和柱的组合,它能够将vB_EcoM_fHoEco02裂解物的内毒素与噬菌体的比例从3.5×10内毒素单位(EU)/10噬斑形成单位(PFU)降至0.09 EU/10 PFU。超滤和阴离子交换色谱的组合导致比例为96 EU/10 PFU,并且在该程序中加入辛醇萃取步骤仍使该比例降低了三倍。测试的其他方法要么导致内毒素去除效率较低,要么需要使用在生产医用噬菌体制剂时应避免的有害化学物质。用100,000 MWCO的超滤有效地从vB_SauM_fRuSau02裂解物中去除了肠毒素(从1.3降至0.06 ng SEA/10 PFU),并且阴离子交换色谱将肠毒素浓度降低至低于0.25 ng/ml,即该测定的检测限。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3e4/6664067/eed2809e2d4a/fmicb-10-01674-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验